Clinical Trials Browser

Completed × elotuzumab × 30 days × Clear all

NCT02719613 2026-04-15

Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab

Phase 2 Completed

Multiple Myeloma